We are a biotech AI company helping pharmaceutical companies design vaccines and immunotherapies. We model MHC binding to peptides, and with generative AI, we generate candidates of the antigens.
Our previous project was recognised by the Polish Health Ministry and deployed in a programme where our software processed more than 50% of all Polish PCR test results.
We spent the last 18 months refining the technology and assembling a team of 12 scientists, AI engineers and PhDs.